In Vitro Antimalarial Activity of a New Organometallic Analog, Ferrocene-Chloroquine
AUTOR(ES)
Domarle, O.
FONTE
American Society for Microbiology
RESUMO
The in vitro activities of new organometallic chloroquine analogs, based on 4-amino-quinoleine compounds bound to a molecule of ferrocene, were evaluated against chloroquine-susceptible, chloroquine-intermediate, and chloroquine-resistant, culture-adapted Plasmodium falciparum lineages by a proliferation test. One of the ferrocene analogs totally restored the activity of chloroquine against chloroquine-resistant parasites. This compound, associated with tartaric acid for better solubility, was highly effective. The role of the ferrocene in reversing chloroquine resistance is discussed, as is its potential use for human therapy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=105495Documentos Relacionados
- In vitro activity of U-57930E, a new clindamycin analog, against aerobic gram-positive bacteria.
- Activity of P536, a UDP-glucose analog, against Trypanosoma cruzi.
- Oral Activity of a Methylenecyclopropane Analog, Cyclopropavir, in Animal Models for Cytomegalovirus Infections
- In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid Analog
- New quinoline di-Mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine, or pyronaridine.